![Fredrik Ullman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fredrik Ullman holds the position of Chief Executive Officer of Vimian Group AB.
| Companies | Position | Start |
|---|---|---|
Innoverse GmbH | Corporate Officer/Principal | - |
| Companies | Position | End |
|---|---|---|
| VIMIAN GROUP AB | Chief Executive Officer | 31/12/2023 |
Indical Bioscience GmbH
 Indical Bioscience GmbH Miscellaneous Commercial ServicesCommercial Services Engages in development of solutions for molecular and immunological veterinary testing | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 5 |
|---|---|
Royal Institute of Technology
 Royal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Swiss Federal Institute of Technology
 Swiss Federal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Indical Bioscience GmbH
Indical Bioscience GmbH Miscellaneous Commercial ServicesCommercial Services Engages in development of solutions for molecular and immunological veterinary testing | Commercial Services |
Vimian Group AB
 Vimian Group AB BiotechnologyHealth Technology Operates as a animal health company | Health Technology |
Innoverse GmbH |
Select your edition
All financial news and data tailored to specific country editions
